Adherence to Long-Term Therapies - Evidence for Action
(2003; 211 pages) Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentAcknowledgements
Afficher le documentScientific writers
Afficher le documentIntroduction
Afficher le documentTake-home messages
Ouvrir ce répertoire et afficher son contenuSection I - Setting the scene
Ouvrir ce répertoire et afficher son contenuSection II - Improving adherence rates: guidance for countries
Fermer ce répertoireSection III - Disease-Specific Reviews
Ouvrir ce répertoire et afficher son contenuChapter VII - Asthma
Ouvrir ce répertoire et afficher son contenuChapter VIII - Cancer (Palliative care)
Ouvrir ce répertoire et afficher son contenuChapter IX - Depression
Ouvrir ce répertoire et afficher son contenuChapter X - Diabetes
Ouvrir ce répertoire et afficher son contenuChapter XI - Epilepsy
Ouvrir ce répertoire et afficher son contenuChapter XII - Human immunodeficiency virus and acquired immunodeficiency syndrome
Ouvrir ce répertoire et afficher son contenuChapter XIII - Hypertension
Fermer ce répertoireChapter XIV - Tobacco smoking cessation
Afficher le document1. The burden of tobacco smoking
Afficher le document2. Clinical guidelines and therapies available for tobacco smoking cessation
Afficher le document3. Definitions
Afficher le document4. Epidemiology of adherence
Afficher le document5. Factors affecting adherence
Afficher le document6. Interventions for improving adherence
Afficher le document7. Cost, effectiveness and cost-effectiveness of adherence
Afficher le document8. Conclusions
Afficher le document9. References
Ouvrir ce répertoire et afficher son contenuChapter XV - Tuberculosis
Ouvrir ce répertoire et afficher son contenuAnnexes
Ouvrir ce répertoire et afficher son contenuWhere to find a copy of this book
 

5. Factors affecting adherence

Some baseline variables apparently influence adherence to therapy. In one study, mean daily cigarette consumption, expired carbon monoxide, plasma nicotine and cotinine, and Fagerstrom Tolerance Questionnaire (FTQ) scores (44) were significantly higher in the dropout group than in the adherent group (1). Alterman et al. (25) concluded that greater dependence on tobacco was associated with less patch use, indicating that patients who smoked more cigarettes were less adherent to treatment with patches.

Depression is an important psychological factor associated with cessation of smoking. A higher prevalence of depressive symptoms would theoretically increase the risk of nonadherence to treatment (45). Differing results of studies of this association have been reported. Some studies showed that smokers with a history of major depression who were not depressed at the time of a 4-week treatment programme had a lower abstinence rate than did smokers without a history of depression. In another study, smokers with a history of major depression in an 8-week multicomponent cognitive behavioural group plus nicotine-gum programme, had a significantly higher abstinence rate than smokers with a history of depression who were treated with nicotine plus a standard programme of information (3,45). Ginsberg et al. suggested that cognitive - behavioural sessions emphasizing group cohesion and social support among smokers with a history of depression maintains adherence in this population (45). A satisfactory explanation of this link will require further research (3,24,31).

Other variables, such as gender, racial or ethnic background, history of psychiatric pathology (25), weight gain (29,30), craving and withdrawal symptoms are reported as being potential predictors of patch adherence. However, because there are no validated measures of these variables, the available data are insufficient to assess their effects on adherence.

During an NRT programme, investigators observed some factors that had a positive effect on adherence. These included motivation (25), attendance at cessation classes, access to free NRT, higher education levels, older age, advice from physicians (26), and more frequent contact with physicians and pharmacists

(35). These factors were also reported as predictive of success in stopping smoking. The analysis of the studies showed that these factors have proven to be statistically significant in increasing abstinence rates, but there is no measure proving their association with adherence.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013